These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16244481)

  • 21. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.
    Devanand DP; Marder K; Michaels KS; Sackeim HA; Bell K; Sullivan MA; Cooper TB; Pelton GH; Mayeux R
    Am J Psychiatry; 1998 Nov; 155(11):1512-20. PubMed ID: 9812111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial.
    Asadollahi S; Heidari K; Hatamabadi H; Vafaee R; Yunesian S; Azadbakht A; Mirmohseni L
    Int Clin Psychopharmacol; 2015 May; 30(3):142-50. PubMed ID: 25500684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olanzapine versus haloperidol in the management of borderline personality disorder: a randomized double-blind trial.
    Shafti SS; Shahveisi B
    J Clin Psychopharmacol; 2010 Feb; 30(1):44-7. PubMed ID: 20075647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease.
    Clark WS; Street JS; Feldman PD; Breier A
    J Clin Psychiatry; 2001 Jan; 62(1):34-40. PubMed ID: 11235926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease.
    Auchus AP; Bissey-Black C
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):591-3. PubMed ID: 9447502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial.
    Kennedy JS; Jeste D; Kaiser CJ; Golshan S; Maguire GA; Tollefson G; Sanger T; Bymaster FP; Kinon BJ; Dossenbach M; Gilmore JA; Breier A
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1013-20. PubMed ID: 14618553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
    Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD).
    Gareri P; Cotroneo A; Lacava R; Seminara G; Marigliano N; Loiacono A; De Sarro G
    Arch Gerontol Geriatr Suppl; 2004; (9):207-15. PubMed ID: 15207416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms.
    Jones B; Taylor CC; Meehan K
    J Clin Psychiatry; 2001; 62 Suppl 2():22-4. PubMed ID: 11232747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
    Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease.
    Devanand DP; Pelton GH; Cunqueiro K; Sackeim HA; Marder K
    Int J Geriatr Psychiatry; 2011 Sep; 26(9):937-43. PubMed ID: 21845596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olanzapine and haloperidol in first episode psychosis: two-year data.
    Green AI; Lieberman JA; Hamer RM; Glick ID; Gur RE; Kahn RS; McEvoy JP; Perkins DO; Rothschild AJ; Sharma T; Tohen MF; Woolson S; Zipursky RB;
    Schizophr Res; 2006 Sep; 86(1-3):234-43. PubMed ID: 16887334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
    Andrezina R; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; McQuade RD
    Curr Med Res Opin; 2006 Nov; 22(11):2209-19. PubMed ID: 17076982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
    Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
    J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intramuscular olanzapine in the management of acute agitation.
    Tulloch KJ; Zed PJ
    Ann Pharmacother; 2004 Dec; 38(12):2128-35. PubMed ID: 15522977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are low doses of antipsychotics effective in the management of psychomotor agitation? A randomized, rated-blind trial of 4 intramuscular interventions.
    Mantovani C; Labate CM; Sponholz A; de Azevedo Marques JM; Guapo VG; de Simone Brito dos Santos ME; Pazin-Filho A; Del-Ben CM
    J Clin Psychopharmacol; 2013 Jun; 33(3):306-12. PubMed ID: 23609398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 4-week, double-blind comparison of olanzapine with haloperidol in the treatment of amphetamine psychosis.
    Leelahanaj T; Kongsakon R; Netrakom P
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S43-52. PubMed ID: 16858942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.